Again Dietmaier et al. investigated nuclear maspin expression in 172 primary stage III colon cancers showing a significant treatment benefit from 5-FU-based chemotherapy in patients with primary tumors expressing Maspin in the nucleus. The gene discussed is SERPINB5; the disease is malignant colon neoplasm.